Skip to main content
ChemoMetec logo

ChemoMetec — Investor Relations & Filings

Ticker · CHEMM ISIN · DK0060055861 LEI · 213800533NBKECGONO68 CO Manufacturing
Open in API
Filings indexed 540 across all filing types
Latest filing 2019-11-29 Board/Management Inform…
Country DK Denmark
Listing CO CHEMM

About ChemoMetec

https://chemometec.com

ChemoMetec is a global manufacturer specializing in high-precision automated cell counting and analysis instrumentation. The company develops and produces a range of advanced image cytometers and cell density analyzers, including the NucleoCounter® and XcytoMatic® series. These systems provide consistent, reproducible, and accurate cell count and viability data for a wide range of cell types. Key technologies include fluorescence microscopy, which enables trypan blue-free analysis, and specialized consumables designed to minimize human error. ChemoMetec's instruments are designed for regulated environments, offering software solutions compliant with FDA 21 CFR Part 11 and supporting Good Manufacturing Practice (GMP) workflows. The company serves customers in the biotechnology, pharmaceutical, and academic sectors, with applications in cell and gene therapy, cancer research, and bioprocessing.

Recent filings

Filing Released Lang Actions
Board/Management Information 2019
Board/Management Information Classification · 99% confidence The document is a short announcement (1075 chars) titled 'MEDDELELSE NR. 178' dated November 29, 2019. The content explicitly states 'Ændringer i ledelsen' (Changes in management) and announces a decision regarding a change in the executive board ('ændring i direktionen'). It also mentions a request for suspension of the stock. The primary subject matter aligns directly with the definition of Board/Management Information (MANG). Although it mentions stock suspension (DLST), the core news is the management change.
2019-11-29 English
Board/Management Information 2019
Board/Management Information Classification · 98% confidence The document is a short announcement (1210 characters) titled "Ændringer i ledelsen og suspension af aktien" (Changes in management and suspension of the share). It explicitly states a decision regarding a change in the executive management ('Ny direktør forventes at kunne tiltræde snarest muligt') and requests a suspension of the stock ('anmodes Fondsbørsen hermed om suspension af aktien'). This directly relates to changes in senior management. The definition for Board/Management Information (MANG) covers 'Announcement of changes in the company's board of directors or senior management.' Although it also mentions a stock suspension, the primary driver appears to be the management change announcement. It is not a full report, so RPA/RNS is less specific than MANG.
2019-11-29 Danish
Transaction in Own Shares 2019
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement (MEDDELELSE NR. 177) dated November 8, 2019, titled 'Salg af egne aktier i ChemoMetec A/S' (Sale of own shares in ChemoMetec A/S). It explicitly states that the company has divested its holding of treasury shares (1,149,000 shares) and now owns no treasury shares. This action directly relates to the company buying back or selling its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is short and is the primary announcement of the transaction, not an announcement of a report.
2019-11-08 Danish
Transaction in Own Shares 2019
Transaction in Own Shares Classification · 100% confidence The document is titled 'Salg af egne aktier i ChemoMetec A/S' (Sale of own shares in ChemoMetec A/S) and explicitly states that the company has divested its holding of 1,149,000 treasury shares. This action directly relates to the company's own share capital management, specifically the disposal of treasury stock. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is short and acts as a direct announcement of the transaction, not a general regulatory filing or a report announcement.
2019-11-08 Danish
Opjustering af omsætning og driftsresultat
Regulatory Filings Classification · 98% confidence The document is a short announcement (MEDDELELSE NR. 175) from ChemoMetec A/S. It explicitly states that the company is 'opjusterer forventningerne' (upgrading expectations) for revenue and operating profit based on a better-than-expected start to the fiscal year 2019/20. Crucially, it mentions that the 'kvartalsmeddelelse for 1. kvartal 2019/20 forventes offentliggjort onsdag den 6. november 2019' (the quarterly report for Q1 2019/20 is expected to be published on Wednesday, November 6, 2019). Since this document is an announcement about financial performance changes and the upcoming release of a quarterly report, it aligns best with the 'Earnings Release' (ER) category, which covers initial announcements of periodical financial results (key highlights only). Although it mentions the upcoming quarterly report, the core content is the immediate financial update/guidance change, which is the essence of an ER.
2019-10-21 Danish
Earnings Release 2019
Earnings Release Classification · 100% confidence The document is a short announcement (1566 characters) titled "Opjustering af omsætning og driftsresultat" (Upgrade of revenue and operating result). It explicitly states that the company is upgrading its expectations for revenue and operating profit based on better-than-expected demand. Crucially, it mentions that the 'kvartalsmeddelelse' (quarterly announcement) for Q1 2019/20 is expected to be published on a future date (November 6, 2019). This structure—a brief update on financial guidance followed by a mention of when the full report will arrive—is characteristic of an Earnings Release (ER) or a preliminary announcement leading up to it. Since it provides specific updated figures (revenue DKK 200–209 mio. vs. 193-202 mio.; EBITDA DKK 67-73 mio. vs. 60-66 mio.), it is more than just a notice of publication (RPA). It is the initial announcement of revised key financial results/guidance, fitting the definition of an Earnings Release (ER). Q1 2019
2019-10-21 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.